BEETATALASSEEMIA KESKMINE JA KERGE VORM
Toetav ravi
eesti
Toetav ravi
/assets/ct/b025754cdb/images/syn_placeholder_sqr.png

Beetatalasseemia keskmine ja kerge vorm

Toetav ravi

Raua kelaatimine

Iron out for nontransfused thalassemia. (avab uue akna)

Marks PW.

Allikas‎: Blood 2012;120(5):928-9.

Indekseeritud‎: PubMed 22859709

DOI‎: 10.1182/blood-2012-06-433227

https://www.ncbi.nlm.nih.gov/pubmed/22859709 (avab uue akna)

Iron overload in β-thalassemia intermedia: an emerging concern. (avab uue akna)

Musallam KM, Cappellini MD, Taher AT.

Allikas‎: Curr Opin Hematol 2013;20(3):187-92.

Indekseeritud‎: PubMed 23426199

DOI‎: 10.1097/MOH.0b013e32835f5a5c

https://www.ncbi.nlm.nih.gov/pubmed/23426199 (avab uue akna)

Toidulisandid ja muud toetavad ravimeetodid

Treatment with bosentan in a patient with thalassemia intermedia and pulmonary arterial hypertension. (avab uue akna)

Anthi A, Tsangaris I, Hamodraka ES, Lekakis J, Armaganidis A, Orfanos SE.

Allikas‎: Blood 2012;120(7):1531-2.

Indekseeritud‎: PubMed 22899478

DOI‎: 10.1182/blood-2012-04-422568

https://www.ncbi.nlm.nih.gov/pubmed/22899478 (avab uue akna)

Prevalance of iron deficiency in thalassemia minor: a study from tertiary hospital. (avab uue akna)

Dolai TK, Nataraj KS, Sinha N, Mishra S, Bhattacharya M, Ghosh MK.

Allikas‎: Indian J Hematol Blood Transfus 2012;28(1):7-9.

Indekseeritud‎: PubMed 23449336

DOI‎: 10.1007/s12288-011-0088-9

https://www.ncbi.nlm.nih.gov/pubmed/23449336 (avab uue akna)

Therapeutic roles of curcumin: lessons learned from clinical trials. (avab uue akna)

Gupta SC, Patchva S, Aggarwal BB.

Allikas‎: AAPS J 2013;15(1):195-218.

Indekseeritud‎: PubMed 23143785

DOI‎: 10.1208/s12248-012-9432-8

https://www.ncbi.nlm.nih.gov/pubmed/23143785 (avab uue akna)

Vitamin E supplement improves erythrocyte membrane fluidity of thalassemia: an ESR spin labeling study. (avab uue akna)

Sutipornpalangkul W, Morales NP, Unchern S, Sanvarinda Y, Chantharaksri U, Fucharoen S.

Allikas‎: J Med Assoc Thai 2012;95(1):29-36.

Indekseeritud‎: PubMed 22379738

https://www.ncbi.nlm.nih.gov/pubmed/22379738 (avab uue akna)

Deferasirox demonstrates a dose-dependent reduction in liver iron concentration and consistent efficacy across subgroups of non-transfusion-dependent thalassemia patients. (avab uue akna)

Taher AT, Porter JB, Viprakasit V, Kattamis A, Chuncharunee S, Sutcharitchan P, Siritanaratkul N, Galanello R, Karakas Z, Lawniczek T, Habr D, Ros J, Zhang Y, Cappellini MD.

Allikas‎: Am J Hematol 2013;88(6):503-6.

Indekseeritud‎: PubMed 23553596

DOI‎: 10.1002/ajh.23445

https://www.ncbi.nlm.nih.gov/pubmed/23553596 (avab uue akna)